222 related articles for article (PubMed ID: 35770411)
1. Mechanistic and Etiological Similarities in Diabetes Mellitus and Alzheimer's Disease: Antidiabetic Drugs as Optimistic Therapeutics in Alzheimer's Disease.
Das S; Ramachandran AK; Halder D; Akbar S; Ahmed B; Joseph A
CNS Neurol Disord Drug Targets; 2023; 22(7):973-993. PubMed ID: 35770411
[TBL] [Abstract][Full Text] [Related]
2. Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin.
Ali SK; Ali RH
PLoS One; 2022; 17(7):e0271138. PubMed ID: 35802659
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic Drugs in the Treatment of Alzheimer's Disease.
Michailidis M; Tata DA; Moraitou D; Kavvadas D; Karachrysafi S; Papamitsou T; Vareltzis P; Papaliagkas V
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563031
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease and type 2 diabetes mellitus: similarities in pathomechanisms lead to therapeutic opportunities.
Bednarz K; Siuda J
Neurol Neurochir Pol; 2021; 55(5):418-428. PubMed ID: 34355790
[TBL] [Abstract][Full Text] [Related]
5. [Alzheimer's disease and diabetes - the common pathogenesis].
Halmos T; Suba I
Neuropsychopharmacol Hung; 2016 Mar; 18(1):5-19. PubMed ID: 27038867
[TBL] [Abstract][Full Text] [Related]
6. New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer's disease.
Pradhan SP; Sahu PK; Behera A
Mol Cell Biochem; 2023 Dec; 478(12):2739-2762. PubMed ID: 36949264
[TBL] [Abstract][Full Text] [Related]
7. Diabetes drugs in the fight against Alzheimer's disease.
Boccardi V; Murasecco I; Mecocci P
Ageing Res Rev; 2019 Sep; 54():100936. PubMed ID: 31330313
[TBL] [Abstract][Full Text] [Related]
8. Ameliorating effect of anti-Alzheimer's drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer's disease.
Ahmed AS; Elgharabawy RM; Al-Najjar AH
Exp Biol Med (Maywood); 2017 Jul; 242(13):1335-1344. PubMed ID: 28534431
[TBL] [Abstract][Full Text] [Related]
9. Is Alzheimer's disease a type 3 diabetes? A review.
Janoutová J; Machaczka O; Zatloukalová A; Janout V
Cent Eur J Public Health; 2022 Sep; 30(3):139-143. PubMed ID: 36239360
[TBL] [Abstract][Full Text] [Related]
10. Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones.
Cardoso S; Moreira PI
Int Rev Neurobiol; 2020; 155():37-64. PubMed ID: 32854858
[TBL] [Abstract][Full Text] [Related]
11. Repurposing and clinical attributes of antidiabetic drugs for the treatment of neurodegenerative disorders.
Birajdar SV; Mazahir F; Alam MI; Kumar A; Yadav AK
Eur J Pharmacol; 2023 Dec; 961():176117. PubMed ID: 37907134
[TBL] [Abstract][Full Text] [Related]
12. New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease.
Zhong KL; Chen F; Hong H; Ke X; Lv YG; Tang SS; Zhu YB
Metab Brain Dis; 2018 Aug; 33(4):1009-1018. PubMed ID: 29626315
[TBL] [Abstract][Full Text] [Related]
13. Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review.
Mittal K; Katare DP
Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S144-9. PubMed ID: 26907971
[TBL] [Abstract][Full Text] [Related]
14. Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment.
Li X; Song D; Leng SX
Clin Interv Aging; 2015; 10():549-60. PubMed ID: 25792818
[TBL] [Abstract][Full Text] [Related]
15. Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives.
Femminella GD; Bencivenga L; Petraglia L; Visaggi L; Gioia L; Grieco FV; de Lucia C; Komici K; Corbi G; Edison P; Rengo G; Ferrara N
J Diabetes Res; 2017; 2017():7420796. PubMed ID: 28656154
[TBL] [Abstract][Full Text] [Related]
16. Type 2 Diabetes Mellitus and Alzheimer's Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets.
Hamzé R; Delangre E; Tolu S; Moreau M; Janel N; Bailbé D; Movassat J
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499613
[TBL] [Abstract][Full Text] [Related]
17. The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.
Watson GS; Craft S
CNS Drugs; 2003; 17(1):27-45. PubMed ID: 12467491
[TBL] [Abstract][Full Text] [Related]
18. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.
Infante-Garcia C; Ramos-Rodriguez JJ; Hierro-Bujalance C; Ortegon E; Pickett E; Jackson R; Hernandez-Pacho F; Spires-Jones T; Garcia-Alloza M
Mol Neurobiol; 2018 Jul; 55(7):6130-6144. PubMed ID: 29224179
[TBL] [Abstract][Full Text] [Related]
19. Type 2 Diabetes Mellitus and Alzheimer's Disease: A Review of the Potential Links.
Pakdin M; Toutounchian S; Namazi S; Arabpour Z; Pouladi A; Afsahi S; Poudineh M; Nasab MMM; Yaghoobpoor S; Deravi N
Curr Diabetes Rev; 2022; 18(8):e051121197760. PubMed ID: 34749616
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease?
Ahn KC; Learman CR; Baker GB; Weaver CL; Chung PS; Kim HG; Song MS
J Korean Med Sci; 2019 Dec; 34(46):e297. PubMed ID: 31779058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]